Chelsea Counsel Company’s Moderna MRNA Stock Holding History

Chelsea Counsel Company’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.08K	Hold	100	–	–	﹤0.01%	187
2025 Q4	$2.95K	Sell	100 -2	-2%	-$54	﹤0.01%	199
2025 Q3	$2.63K	Hold	102	–	–	﹤0.01%	201
2025 Q2	$2.81K	Hold	102	–	–	﹤0.01%	193
2025 Q1	$2.89K	Sell	102 -6,757	-99%	-$240K	﹤0.01%	190
2024 Q4	$285K	Sell	6,859 -545	-7%	-$26K	0.15%	85
2024 Q3	$495K	Sell	7,404 -635	-8%	-$58.3K	0.24%	68
2024 Q2	$955K	Buy	8,039 +4,005	+99%	+$507K	0.48%	43
2024 Q1	$430K	Sell	4,034 -198	-5%	-$20K	0.24%	62
2023 Q4	$421K	Sell	4,232 -1,550	-27%	-$130K	0.22%	72
2023 Q3	$597K	Sell	5,782 -70	-1%	-$7.81K	0.31%	63
2023 Q2	$711K	Buy	5,852 +70	+1%	+$9.34K	0.35%	58
2023 Q1	$888K	Hold	5,782	–	–	0.43%	51
2022 Q4	$1.04M	Sell	5,782 -420	-7%	-$68.7K	0.52%	47
2022 Q3	$733K	Sell	6,202 -50	-0.8%	-$7.59K	0.45%	54
2022 Q2	$893K	Sell	6,252 -128	-2%	-$18.3K	0.46%	52
2022 Q1	$1.1M	Sell	6,380 -25	-0.4%	-$4.21K	0.48%	47
2021 Q4	$1.63M	Buy	+6,405	New	+$1.87M	0.7%	35

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return